USD 23.15
(-1.53%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 5.39 Billion USD | -3.3% |
2022 | 5.58 Billion USD | -5.02% |
2021 | 5.87 Billion USD | 3.27% |
2020 | 5.68 Billion USD | -10.75% |
2019 | 6.37 Billion USD | -4.17% |
2018 | 6.65 Billion USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 5.13 Billion USD | -1.1% |
2024 Q3 | 5.11 Billion USD | -0.53% |
2024 Q1 | 5.19 Billion USD | -3.71% |
2023 Q2 | 5.36 Billion USD | -1.09% |
2023 FY | 5.39 Billion USD | -3.3% |
2023 Q4 | 5.39 Billion USD | 1.66% |
2023 Q3 | 5.3 Billion USD | -1.11% |
2023 Q1 | 5.42 Billion USD | -2.75% |
2022 Q2 | 5.8 Billion USD | -1.31% |
2022 Q1 | 5.88 Billion USD | 0.15% |
2022 FY | 5.58 Billion USD | -5.02% |
2022 Q4 | 5.58 Billion USD | -3.04% |
2022 Q3 | 5.75 Billion USD | -0.89% |
2021 Q1 | 5.97 Billion USD | 5.08% |
2021 Q4 | 5.87 Billion USD | -0.81% |
2021 FY | 5.87 Billion USD | 3.27% |
2021 Q3 | 5.92 Billion USD | -1.34% |
2021 Q2 | 6 Billion USD | 0.42% |
2020 Q2 | 6.36 Billion USD | 16084.48% |
2020 Q4 | 5.68 Billion USD | -11.96% |
2020 FY | 5.68 Billion USD | -10.75% |
2020 Q3 | 6.46 Billion USD | 1.46% |
2020 Q1 | 39.35 Million USD | -99.38% |
2019 Q1 | - USD | 0.0% |
2019 FY | 6.37 Billion USD | -4.17% |
2019 Q4 | 6.37 Billion USD | 0.0% |
2018 FY | 6.65 Billion USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
American Well Corporation | 109.51 Million USD | -4827.456% |
Doximity, Inc. | 177.97 Million USD | -2932.134% |
Evolent Health, Inc. | 1.61 Billion USD | -234.645% |
Phreesia, Inc. | 119.63 Million USD | -4410.767% |
Teladoc Health, Inc. | 2.06 Billion USD | -161.168% |
Veeva Systems Inc. | 1.26 Billion USD | -326.232% |